What metrics would you use to evaluate Tandem Diabetes Care's Control-IQ technology?

Introduction

Evaluating the success of Tandem Diabetes Care's Control-IQ technology requires a comprehensive approach to product metrics. This automated insulin delivery system represents a significant advancement in diabetes management, and its impact must be measured across multiple dimensions. I'll follow a structured framework that covers core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Control-IQ is an advanced hybrid closed-loop system that works with Tandem's t:slim X2 insulin pump and Dexcom G6 continuous glucose monitor (CGM). It automatically adjusts insulin delivery based on predicted glucose levels, aiming to keep blood sugar in target range.

Key stakeholders include:

• Patients with type 1 diabetes: Seeking better glucose control and quality of life
• Healthcare providers: Looking for effective tools to manage patient outcomes
• Payers: Interested in long-term health outcomes and cost reduction
• Regulators: Ensuring safety and efficacy of medical devices

User flow:

1. Patient wears t:slim X2 pump and Dexcom G6 CGM
2. Control-IQ algorithm continuously analyzes glucose data
3. System automatically adjusts insulin delivery as needed
4. User can override or supplement automated dosing when necessary

Control-IQ fits into Tandem's strategy of creating an artificial pancreas system, positioning them as a leader in diabetes technology. It competes with Medtronic's MiniMed 780G and Insulet's Omnipod 5 systems, offering unique features like sleep and exercise modes.

Product Lifecycle Stage: Early Growth - Control-IQ is past initial launch but still expanding its user base and refining its technology.

Hardware considerations:

• Integration with existing Tandem pumps and Dexcom CGMs
• Firmware update capabilities for existing users
• Battery life and durability of devices

Software considerations:

• Algorithm refinement and machine learning capabilities
• Data security and HIPAA compliance
• Integration with diabetes management apps and healthcare systems